Department of Dermatology - Open Access Policy Deposits
Parent: School of Medicine
eScholarship stats: Breakdown by Item for October, 2024 through January, 2025
| Item | Title | Total requests | Download | View-only | %Dnld |
|---|---|---|---|---|---|
| 3455571b | Amitriptyline-induced cutaneous hyperpigmentation: case report and review of psychotropic drug-associated mucocutaneous hyperpigmentation | 210 | 31 | 179 | 14.8% |
| 5r79d67k | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: report of a case and review of the literature | 131 | 37 | 94 | 28.2% |
| 25q9w6r9 | Dupilumab for bullous pemphigoid with intractable pruritus | 120 | 29 | 91 | 24.2% |
| 85m1b2b9 | The microbiome in patients with atopic dermatitis. | 96 | 21 | 75 | 21.9% |
| 5d2509br | Retinoids Enhance the Expression of Cathelicidin Antimicrobial Peptide during Reactive Dermal Adipogenesis | 79 | 0 | 79 | 0.0% |
| 3sk3c211 | Antimicrobials from a feline commensal bacterium inhibit skin infection by drug-resistant S. pseudintermedius | 77 | 4 | 73 | 5.2% |
| 6hz8s1mh | Eccrine chromhidrosis secondary to hyperbilirubinemia | 74 | 11 | 63 | 14.9% |
| 0793n5z2 | Isotretinoin therapy for the treatment of acne in patients with cystic fibrosis: a case series and review of the literature | 70 | 21 | 49 | 30.0% |
| 02k9z6qd | Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations | 69 | 18 | 51 | 26.1% |
| 6xc3r0r5 | Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis | 67 | 3 | 64 | 4.5% |
| 5xs3g48j | Acne and Rosacea | 59 | 48 | 11 | 81.4% |
| 14v8m1f6 | Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants | 56 | 16 | 40 | 28.6% |
| 6t87g6qr | The Ubiquitous Human Skin Commensal Staphylococcus hominis Protects against Opportunistic Pathogens | 50 | 20 | 30 | 40.0% |
| 3hb946cs | Functions of the skin microbiota in health and disease | 49 | 34 | 15 | 69.4% |
| 47q8p2w7 | Nevoid melanoma and eruptive nevi from erlotinib | 49 | 10 | 39 | 20.4% |
| 8p66q9fv | Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum | 46 | 6 | 40 | 13.0% |
| 0n77t015 | Lymphomatoid papulosis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: case report and literature review | 41 | 7 | 34 | 17.1% |
| 1xf7w7x4 | Characteristics of research tracks in dermatology residency programs: a national survey | 40 | 7 | 33 | 17.5% |
| 39n4p5d6 | Continuity of care in dermatology residency programs in the United States | 40 | 6 | 34 | 15.0% |
| 3m92791x | Emerging Issues in Adult Female Acne. | 38 | 27 | 11 | 71.1% |
| 0sg0z14s | Genitogluteal porokeratosis in an HIV-positive man: a case report and review of the literature on genital porokeratosis | 37 | 10 | 27 | 27.0% |
| 1mr6n17z | Defining the activity of pro-reparative extracellular vesicles in wound healing based on miRNA payloads and cell type-specific lineage mapping | 37 | 2 | 35 | 5.4% |
| 2xn7z5c4 | Botulinum toxin blocks mast cells and prevents rosacea like inflammation | 36 | 24 | 12 | 66.7% |
| 2qr3w771 | Urgent safety considerations for dermatologic surgeons in the COVID-19 pandemic | 34 | 3 | 31 | 8.8% |
| 2800q59v | TREM2 macrophages induced by human lipids drive inflammation in acne lesions | 33 | 20 | 13 | 60.6% |
| 3pz734ck | Regulation of AMPK activation by extracellular matrix stiffness in pancreatic cancer. | 33 | 17 | 16 | 51.5% |
| 19t31479 | Evolving approaches to profiling the microbiome in skin disease | 32 | 11 | 21 | 34.4% |
| 68c7v95d | Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome | 32 | 12 | 20 | 37.5% |
| 4pn6h3g6 | The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis | 31 | 12 | 19 | 38.7% |
| 1bk078v9 | Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP) | 30 | 15 | 15 | 50.0% |
| 47p4d8zv | Penicillamine-associated cutis laxa and milia en plaque - case report and review of cutaneous changes associated with penicillamine | 30 | 9 | 21 | 30.0% |
| 55q795hc | Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis | 30 | 13 | 17 | 43.3% |
| 62d7n4g9 | Designing a broad-spectrum integrative approach for cancer prevention and treatment | 30 | 12 | 18 | 40.0% |
| 5fs883zh | Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. | 28 | 1 | 27 | 3.6% |
| 25j8m068 | Antimicrobial production by perifollicular dermal preadipocytes is essential to the pathophysiology of acne | 27 | 10 | 17 | 37.0% |
| 53x2q5k3 | Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting | 27 | 18 | 9 | 66.7% |
| 2bv4q0k3 | Obesity alters pathology and treatment response in inflammatory disease | 26 | 3 | 23 | 11.5% |
| 2dn263n7 | Skin neurogenic inflammation | 26 | 5 | 21 | 19.2% |
| 7vq68882 | Dynamic interplay between IL-1 and WNT pathways in regulating dermal adipocyte lineage cells during skin development and wound regeneration | 25 | 15 | 10 | 60.0% |
| 8z66m3xd | Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial | 25 | 7 | 18 | 28.0% |
| 9t16k3hw | Evaluation of stenoses using AI video models applied to coronary angiography. | 24 | 8 | 16 | 33.3% |
| 9xk8c429 | Diaper dermatitis prevalence and severity: Global perspective on the impact of caregiver behavior | 24 | 8 | 16 | 33.3% |
| 216788xg | Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study. | 23 | 10 | 13 | 43.5% |
| 3zr2w6xs | Staphylococcus aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression | 23 | 6 | 17 | 26.1% |
| 0qg1x3kj | A Platform to Study the Effects of Electrical Stimulation on Immune Cell Activation During Wound Healing. | 22 | 14 | 8 | 63.6% |
| 51p3x2df | Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR‐γ selective topical retinoid, in patients with moderate facial and truncal acne | 21 | 14 | 7 | 66.7% |
| 7gn5j3gp | Incomplete human reference genomes can drive false sex biases and expose patient-identifying information in metagenomic data | 21 | 0 | 21 | 0.0% |
| 9r8758sd | Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis | 21 | 4 | 17 | 19.0% |
| 0vp716bx | Pediatric chronic hand eczema: Epidemiology, clinical presentation, and management | 20 | 11 | 9 | 55.0% |
| 7h55s5k7 | Increasing the Efficacy of Stem Cell Therapy via Triple-Function Inorganic Nanoparticles | 20 | 11 | 9 | 55.0% |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.